you are viewing a single comment's thread.
Teva looks good in terms of it's value. If you like healthcare what about ESRX? It's a bit pricier.ESRX rev. growth ttm vs prior ttm= 82.18%TEVA by comparison= 15.99%Both look like good buys to me. Just different parts of the healthcare boat.
I've looked at ESRX from time to time, sure wish I'd been long years ago. 2009 presented one of the few good buying dips.But I still prefer TEVA since they produce a product rather than a service.... just me.
F had a big correction, but is up almost 5% today... has done me right in the past. Go F.
ESRX is a well managed company and that's why I like it. It tends to be chronically overvalued just like CTSH, another favorite of mine. FDS is another good one that is always pricey.Many of my winners have been tended to have higher than average ttm p/e's but I'm not comfortable paying more than around 30 times earnings.BTW....I took added to my GOOG position last week. GOOG looks pretty cheap to me. APPL still looking like a buy but I'm already overloaded in APPL.
I have always been interested in ESRX but never bot. Could be a good opportunity now.